Floatz logo

IRON SUCROSE

Iron Deficiency Anemia

University of Wisconsin, MadisonOtherPhase 4 / ApprovedDormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
36/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Iron Deficiency Anemia cohort.

Asset / SponsorPhaseRating
FERRIC CATION
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 4A
Iron Isomaltoside
China-Japan Friendship Hospital
Phase 4BBB
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Linda Malan
Phase 4BBB
SODIUM FERRIC GLUCONATE
Watson Pharmaceuticals
Phase 4BBB
Iron
Cairo University
Phase 4BB

View all 13 →

Same molecule, other indications

IRON SUCROSE is also rated in:

colorectal neoplasmDormant
CC
Indicative ·
47 / 100
View asset →
anemiaDormant
C
Indicative ·
37 / 100
View asset →
ovarian carcinomaDormant
C
Indicative ·
35 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →